![\"\"](\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/08\/OSPRI_4-up-970.jpg\")
<\/p>\n <\/p>\n
OSPRI co-founders, left to right: Steve M. Sorey, Jeremy Adamic, Dr. Alaina Vincent, and Randy Phelps [Photos: OSPRI]<\/p>\n
A $30 million merger among Community Direct DX (CDx), Scienetix, and the R&D division of Advanta Genetics has formed McKinney-based OSPRI, a next-generation biotechnology company and \u201cone of the world\u2019s first fully vertically integrated\u201d molecular testing platforms.<\/strong><\/p>\n OSPRI specializes in polymerase chain reaction (PCR)-based infectious disease detection, and it develops and delivers advanced tools that improve access to high-quality care across key healthcare segments\u2014including women\u2019s health, primary care, urgent care, urology, hospitals, and clinical reference laboratories.<\/p>\n \u201cPCR testing is foundational for infectious disease detection, but cost and complexity have kept it out of reach for many,\u201d Co-founder Steve Sorey, partner at OSPRI, said in a statement. \u201cTo unlock widespread adoption, we must reduce both. At OSPRI, we\u2019re obsessed with doing more with less\u2014making PCR faster, cheaper, and better for everyone involved.\u201d<\/p>\n In addition to assay development, OSPRI said it delivers an end-to-end solution\u2014covering manufacturing, lab buildout, revenue cycle management, and regulatory support\u2014empowering providers to operate high-complexity labs in-house with greater speed, accuracy, and financial control.<\/p>\n Funding and leadership<\/p>\n OSPRI said it\u2019s backed by up to $30 million of strategic funding from Catalio Capital Management, a healthcare investment firm with deep expertise in diagnostics. This partnership will support OSPRI\u2019s continued growth, platform development, and national expansion.<\/p>\n \u201cOSPRI delivers a powerful solution for physician groups and laboratories\u2014simplifying infectious disease testing while creating strong clinical and commercial value,\u201d Catalio Partner Jonathan Blankfein said in a statement. \u201cWe\u2019re proud to support their mission to expand access to rapid, provider-centric diagnostics.\u201d<\/p>\n OSPRI\u2019s scientific leadership includes Chief Science Officer Dr. Rahul Sharma, Chief Innovation Officer Dr. Sadia Almas, and Chief Clinical Officer Dr. Alaina Vincent.<\/p>\n Redefining PCR testing<\/p>\n The company said its technology is redefining PCR testing through:<\/p>\n \u00a0 Founded in 2015, Community Direct DX has launched more than 60 labs nationwide. Scienetix brings deep expertise in molecular bioengineering, while Advanta R&D has led advancements in high-resolution genomics and contributed to national public health initiatives.<\/p>\n \u201cOur production capabilities have grown exponentially,\u201d OSPRI Co-Founding Partner Jeremy Adamic said in a statement. \u201cFrom a limited menu and basic QC, we now deliver over 40,000 tests per day with multilayered quality control\u2014scaling both volume and reliability.\u201d<\/p>\n OSPRI said that over the next 12\u201324 months, it plans to expand its R&D team by 40% and grow commercial operations by 25% to meet increasing demand. The company currently serves clients across 20 states and multiple clinical specialties.<\/p>\n \u201cOSPRI exists to solve the real problems of cost and complexity in infectious disease testing,\u201d said Vincent, the company\u2019s chief clinical officer. \u201cInnovation should be accessible\u2014not exclusive. Our goal is to enable better, faster care for more patients by equipping providers with the tools they need to lead.\u201d<\/p>\n Don\u2019t miss what\u2019s next. Subscribe\u00a0to\u00a0Dallas\u00a0Innovates.<\/p>\n Track Dallas-Fort Worth\u2019s business and innovation landscape with our curated news in your inbox Tuesday-Thursday.<\/p>\n \u00a0<\/p>\n \tR E A D\u00a0\u00a0 N E X T\t<\/p>\n New architectural renderings by the Copenhagen-based Bjarke Ingels Group “reflects the resilience and richness of African American culture and aims to foster education, growth, and connection within the community,” the museum said.<\/p>\n<\/li>\n Cx Precision Medicine\u2014a diagnostics company founded on research by Dr. Sid O\u2019Bryant at UNT Health Science Center at Fort Worth\u2014spun out from HSC to advance O\u2019Bryant\u2019s pioneering work on blood-based biomarkers for Alzheimer\u2019s disease and other neurodegenerative conditions. The company recently gained higher visibility\u2014and an even greater opportunity for impact\u2014by being selected to join the prestigious StartUp Health\u2019s Alzheimer\u2019s Moonshot community.<\/p>\n<\/li>\n The $8.6 million grant has been awarded to the city of Dallas on behalf of Fair Park First and the Community Park and will be distributed through the National Park Service\u2019s Land and Water Conservation Fund\u2019s Outdoor Recreation Legacy Partnership Program.<\/p>\n<\/li>\n The Greener Dallas Greater Dallas campaign will further expand TPL’s efforts to create 18 parks with 17 miles of trails and 283 acres of preserved wilderness, the nonprofit said. The announcement came at Saturday’s opening of theJudge Charles R. Rose Community Park, a 40-acre green space along the Five Mile Creek Greenbelt.<\/p>\n<\/li>\n Alphabet-owned health data platform Verily relocated its headquarters to Dallas from San Francisco last year. Now, armed with the new MJFF grant, it aims to generate one of the world’s largest, high-dimensional molecular datasets to advance Parkinson\u2019s disease research.<\/p>\n<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"OSPRI co-founders, left to right: Steve M. Sorey, Jeremy Adamic, Dr. Alaina Vincent, and Randy Phelps [Photos: OSPRI]…\n","protected":false},"author":3,"featured_media":162965,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[94170,94171,94172,94173,815,94174,94175,7813,94176,94177,60244,94178,94179,159,94180,94181,67,132,68],"class_list":{"0":"post-162964","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-advanta-genetics","9":"tag-alaina-vincent","10":"tag-catalio-capital-management","11":"tag-community-direct-dx","12":"tag-genetics","13":"tag-infectious-disease-detection","14":"tag-jonathan-blankfein","15":"tag-merger","16":"tag-ospri","17":"tag-polymerase-chain-reaction","18":"tag-rd","19":"tag-rahul-sharma","20":"tag-sadia-almas","21":"tag-science","22":"tag-scienetix","23":"tag-steve-m-sorey","24":"tag-united-states","25":"tag-unitedstates","26":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115065028912496622","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/162964","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=162964"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/162964\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/162965"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=162964"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=162964"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=162964"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n
\nEnabling \u2018better, faster care\u2019<\/p>\n\n
![\"\"](\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/06\/JuneteenthMuseum_Dropoff_White-970.jpg\")
<\/a><\/p>\n![\"\"](\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/08\/CxPM_2up-970.jpg\")
<\/a><\/p>\n![\"\"](\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/07\/1751726532_962_Rendering-of-a-new-childrens-playground-at-Fair-Park-Community-Park-Complex-Image-by-Rees-Jones-Foun.jpeg\")
<\/a><\/p>\n![\"\"](\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/07\/Sculpture-and-playground-area-at-Judge-Charles-R.-Rose-Community-Park-in-Dallas-Photo-Trust-for-Publ.jpeg\")
<\/a><\/p>\n![\"\"](\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/07\/Michael-J.-Fox-Foundation-Co-Founder-and-CEO-Deborah-W.-Brooks-Founder-Michael-J.-Fox-and-EVP-of-Res.jpeg\")
<\/a><\/p>\n